Drug Profile
HIV vaccine - Biosantech
Alternative Names: HIV-1 vaccine - Biosantech; Tat OyiLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator CNRS; Universite de la Mediterranee
- Developer Biosantech
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II HIV-1 infections